- Web-based
- Cloud-based
- On-premise
The Medical Device Clinical Trials Software Market size was valued at USD 1,408.9 million in 2022 and expected to grow at a CAGR of 14.7% from 2023 to 2029. The global market provides a detailed overview of the Medical Device Clinical Trials Software market and that can be segmented by type of delivery, by software type, and end-user. By Type of Delivery, The medical device clinical trials software market has been segmented into Web-based, Cloud-based, and On-premises. The web-based segment is likely to be the largest and fastest-growing segment in terms of type. Based on end-user the medical device clinical trials software market is segmented into Contract Research Organizations (CROs), Medical Device Manufacturers, and Others. Among these, the contract research organizations (cros) segment is expected to have the fastest-growing market during the forecast period 2023-2029 according to Precision Business Insights.
Medical Device Clinical Trials Software Market Key Developments:
- In December 2021, Optimapharm, a leading European clinical research organization, acquired SSS International. This acquisition helped the company is widening its portfolio of clinical research studies.
Medical Device Clinical Trials Software Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
14.7%
Largest Market
North America
Fastest Growing Market
North America
Medical Device Clinical Trials Software Market Dynamics
The rising prevalence of chronic diseases and the growing need for clinical trials are expected to contribute to the market growth. Clinical trials are gradually increasing in developing economies as the availability for patient recruitment and matching is a crucial part of clinical trials.
North-America got significant share
Medical Device Clinical Trials Software Market Regional Analysis
By region, the North America market is expected to witness highest market share during the forecast period owing to increasing clinical R&D activities of pharma companies, fast adoption of cloud-based technologies, and rising prevalence of various diseases.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The Medical Device Clinical Trials Software Market report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
- The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Medical Device Clinical Trials Software Market Segmentation
By Type of Delivery
By Software Type
- EDC
- eCOA/ePRO
- eConsent
- eCRF
- Others
By End User
- Contract Research Organizations (CROs)
- Medical Device Manufacturers
- Others
Frequently Asked Questions
The Medical Device Clinical Trials Software Market is projected to expand at a CAGR of 14.7% during the forecast period.
The major players in the global medical device clinical trials software market are Axiom, Castor, Clinical Ink, Clinion, ClinOne, Cloudbyz, Crucial Data Solutions (CDS), Datatrak, DM 365, DSG, IBM, Interlace Health, THREAD, TransCelerate Biopharma
North America is the fastest-growing region for Medical Device Clinical Trials Software Market
| 1. Executive Summary |
| 2. Global Medical Device Clinical Trials Software Market Introduction |
| 2.1. Global Medical Device Clinical Trials Software Market Taxonomy |
| 2.2. Global Medical Device Clinical Trials Software Market Definitions |
| 2.2.1. Type of Delivery |
| 2.2.2. Software Type |
| 2.2.3. End User |
| 3. Global Medical Device Clinical Trials Software Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Medical Device Clinical Trials Software Market Dynamic Factors - Impact Analysis |
| 3.6. Global Medical Device Clinical Trials Software Market Competition Landscape |
| 3.7. Epidemiology |
| 4. Global Medical Device Clinical Trials Software Market Analysis,2018 - 2022 and Forecast, 2023 - 2029 |
| 4.1. Market Analysis,2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Medical Device Clinical Trials Software Market, By Type of Delivery, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1. Web-based |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Cloud-based |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. On-premise |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Medical Device Clinical Trials Software Market Forecast, By Software Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1. EDC |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. eCOA/ePRO |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. eConsent |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. eCRF |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Medical Device Clinical Trials Software Market, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1. Contract Research Organizations (CROs) |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Medical Device Manufacturers |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Medical Device Clinical Trials Software Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia-Pacific |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Middle East and Africa |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Medical Device Clinical Trials Software Market - Opportunity Analysis Index, By Type of Delivery, Software Type, End User and Region, 2023 - 2029 |
| 9. North America Medical Device Clinical Trials Software Market Analysis,2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.1. By Type of Delivery Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Web-based |
| 9.1.2. Cloud-based |
| 9.1.3. On-premise |
| 9.2. Software Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. EDC |
| 9.2.2. eCOA/ePRO |
| 9.2.3. eConsent |
| 9.2.4. eCRF |
| 9.2.5. Others |
| 9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Contract Research Organizations (CROs) |
| 9.3.2. Medical Device Manufacturers |
| 9.3.3. Others |
| 9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.4.1. USA |
| 9.4.2. Canada |
| 9.5. North America Medical Device Clinical Trials Software Market - Opportunity Analysis Index, By Type of Delivery, Software Type, End User, and Country, 2023 - 2029 |
| 9.6. North America Medical Device Clinical Trials Software Market Dynamics Trends |
| 10. Europe Medical Device Clinical Trials Software Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 10.1. By Type of Delivery Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Web-based |
| 10.1.2. Cloud-based |
| 10.1.3. On-premise |
| 10.2. Software Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. EDC |
| 10.2.2. eCOA/ePRO |
| 10.2.3. eConsent |
| 10.2.4. eCRF |
| 10.2.5. Others |
| 10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Contract Research Organizations (CROs) |
| 10.3.2. Medical Device Manufacturers |
| 10.3.3. Others |
| 10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Germany |
| 10.4.2. UK |
| 10.4.3. France |
| 10.4.4. Spain |
| 10.4.5. Italy |
| 10.4.6. Russia |
| 10.4.7. Poland |
| 10.4.8. Rest of Europe |
| 10.5. Europe Medical Device Clinical Trials Software Market - Opportunity Analysis Index, By Type of Delivery, Software Type, End User, and Country, 2023 - 2029 |
| 10.6. Europe Medical Device Clinical Trials Software Market Dynamics Trends |
| 11. Asia-Pacific Medical Device Clinical Trials Software Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 11.1. By Type of Delivery Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Web-based |
| 11.1.2. Cloud-based |
| 11.1.3. On-premise |
| 11.2. Software Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. EDC |
| 11.2.2. eCOA/ePRO |
| 11.2.3. eConsent |
| 11.2.4. eCRF |
| 11.2.5. Others |
| 11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Contract Research Organizations (CROs) |
| 11.3.2. Medical Device Manufacturers |
| 11.3.3. Others |
| 11.4. Country Analysis2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Japan |
| 11.4.2. China |
| 11.4.3. India |
| 11.4.4. ASEAN |
| 11.4.5. Australia & New Zealand |
| 11.4.6. Rest of Asia-Pacific |
| 11.5. Asia-Pacific Medical Device Clinical Trials Software Market - Opportunity Analysis Index, By Type of Delivery, Software Type, End User, and Country, 2023 - 2029 |
| 11.6. Asia-Pacific Medical Device Clinical Trials Software Market Dynamics Trends |
| 12. Latin America Medical Device Clinical Trials Software Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 12.1. By Type of Delivery Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Web-based |
| 12.1.2. Cloud-based |
| 12.1.3. On-premise |
| 12.2. Software Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. EDC |
| 12.2.2. eCOA/ePRO |
| 12.2.3. eConsent |
| 12.2.4. eCRF |
| 12.2.5. Others |
| 12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Contract Research Organizations (CROs) |
| 12.3.2. Medical Device Manufacturers |
| 12.3.3. Others |
| 12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Brazil |
| 12.4.2. Mexico |
| 12.4.3. Argentina |
| 12.4.4. Rest of Latin America |
| 12.5. Latin America Medical Device Clinical Trials Software Market - Opportunity Analysis Index, By Type of Delivery, Software Type, End User, and Country, 2023 - 2029 |
| 12.6. Latin America Medical Device Clinical Trials Software Market Dynamics Trends |
| 13. Middle East and Africa Medical Device Clinical Trials Software Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 13.1. By Type of Delivery Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Web-based |
| 13.1.2. Cloud-based |
| 13.1.3. On-premise |
| 13.2. Software Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.2.1. EDC |
| 13.2.2. eCOA/ePRO |
| 13.2.3. eConsent |
| 13.2.4. eCRF |
| 13.2.5. Others |
| 13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Contract Research Organizations (CROs) |
| 13.3.2. Medical Device Manufacturers |
| 13.3.3. Others |
| 13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Gulf Cooperation Council (GCC) Countries |
| 13.4.2. Israel |
| 13.4.3. South Africa |
| 13.4.4. Rest of MEA |
| 13.5. MEA Medical Device Clinical Trials Software Market - Opportunity Analysis Index, By Type of Delivery, Software Type, End User, and Country, 2023 - 2029 |
| 13.6. MEA Medical Device Clinical Trials Software Market Dynamics Trends |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Analysis, Software Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 14.2.1. Axiom |
| 14.2.2. Castor |
| 14.2.3. Clindox |
| 14.2.4. Clinical Ink |
| 14.2.5. Clinion |
| 14.2.6. ClinOne |
| 14.2.7. Cloudbyz |
| 14.2.8. Crucial Data Solutions (CDS) |
| 14.2.9. Datatrak |
| 14.2.10. DM 365 |
| 14.2.11. DSG |
| 14.2.12. IBM |
| 14.2.13. Interlace Health |
| 14.2.14. THREAD |
| 14.2.15. TransCelerate Biopharma |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
- Axiom
- Castor
- Clindox
- Clinical Ink
- Clinion
- ClinOne
- Cloudbyz
- Crucial Data Solutions (CDS)
- Datatrak
- DM 365
- DSG
- IBM
- Interlace Health
- THREAD
- TransCelerate Biopharma